Ayala Pharmaceuticals, Inc.

CIK 1100397 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ayala Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Apr 16, 2025SCHEDULE 13G0001641172-25-005014
May 9, 202415-12G0000929638-24-001751
Apr 26, 202410-K/A0001493152-24-016714
Apr 19, 20248-K/A0000929638-24-001532
Apr 16, 202410-K0001493152-24-014822
Apr 15, 2024S-8 POS0000929638-24-001468
Apr 15, 2024S-8 POS0000929638-24-001471
Apr 15, 2024S-8 POS0000929638-24-001466
Apr 15, 2024S-8 POS0000929638-24-001470
Apr 15, 2024S-8 POS0000929638-24-001473
Apr 15, 2024S-8 POS0000929638-24-001472
Apr 15, 2024S-8 POS0000929638-24-001469
Apr 15, 2024S-8 POS0000929638-24-001474
Apr 15, 2024S-8 POS0000929638-24-001467
Apr 3, 20248-K0000929638-24-001326
Apr 1, 2024NT 10-K0000929638-24-001318
Mar 29, 20248-K0000929638-24-001313
Mar 6, 202440001178913-24-000828
Mar 5, 20248-K0000929638-24-000901
Mar 5, 2024DEFM14C0001493152-24-008783
Feb 23, 20248-K0000929638-24-000753
Feb 20, 2024PREM14C0001493152-24-007260
Feb 14, 2024SC 13G/A0001104659-24-023786
Feb 12, 2024SC 13D/A0001178913-24-000459
Feb 12, 2024SC 13G/A0001178913-24-000455